Beyond Achondroplasia

Growing together with Clara

August 15, 2018
by inesp.alves

QED Tx – a new company working on a treatment for achondroplasia

At the beginning of 2018, QED Therapeutics was launched by Bridge Bio, as a new biotechnology company, focused on precision medicine for FGFR-driven diseases. 1. What are FGFRs? The fibroblast growth factor receptors (FGFRs) regulate important biological processes including cell proliferation … Continue reading

Translate »